A new scientific study suggests that a simple nasal spray may help reduce brain inflammation and improve memory function, potentially slowing aspects of brain ageing.
The findings are based on early-stage research and have so far only been tested in animal models.
What the Study Found
Researchers at Texas A&M University discovered that just two doses of a specially designed nasal spray significantly reduced inflammation in the brain and improved cognitive performance in aging mice.
The treatment appeared to restore memory-related functions within weeks, with effects lasting for several months.
Targeting “Brain Ageing” Inflammation
The research focuses on a process known as neuroinflammaging, which refers to low-level, chronic inflammation in the brain associated with ageing and memory decline.
Scientists believe this inflammation contributes to conditions such as cognitive impairment and neurodegenerative disease.
How the Spray Works
The nasal spray delivers microscopic biological particles called extracellular vesicles into the brain through the nasal passage.
These particles carry genetic material that may help reduce inflammation and support cellular repair in brain tissue.
Improvements in Memory Tests
In experiments involving aging mice, treated subjects showed better performance in memory and learning tests compared to untreated groups.
They were more successful in recognizing familiar objects and adapting to new changes in their environment.
Expert Perspective
Lead researcher Ashok Shetty and his team suggest that this approach may eventually help develop non-invasive treatments for age-related cognitive decline.
However, they emphasize that further testing is required before any human applications can be considered.
Important Limitations
Experts caution that the findings are still in early research stages and have only been demonstrated in animals, not humans.
Results in mice do not always translate directly to human treatments.
What Happens Next
Researchers plan to continue studying how the nasal spray affects brain function and whether similar outcomes can be safely replicated in human trials.
If successful, it could open new pathways for treating age-related memory decline without invasive procedures.
